Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2011, Article ID 578691, 8 pages
http://dx.doi.org/10.1155/2011/578691
Research Article

The Effect of Antivascular Endothelial Growth Factor on the Development of Adhesion Formation in Laparotomized Rats: Experimental Study

1Department of General Surgery, Diyarbakir Education and Research Hospital, 21400 Diyarbakir, Turkey
2Department of General Surgery, Faculty of Medicine, Firat University, 23100 Elazig, Turkey
3Department of Medical Pathology, Faculty of Medicine, Firat University, 23100 Elazig, Turkey

Received 16 February 2011; Accepted 2 May 2011

Academic Editor: Hirozumi Sawai

Copyright © 2011 Murat Basbug et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Ignjatovic, K. Aasland, M. Pettersen et al., “Intra-abdominal administration of bevacizumab diminishes intra-peritoneal adhesions,” American Journal of Surgery, vol. 200, no. 2, pp. 270–275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. W. Hellebrekers, T. C. Trimbos-Kemper, L. Boesten et al., “Preoperative predictors of postsurgical adhesion formation and the prevention of adhesions with plasminogen activator (PAPA-study): results of a clinical pilot study,” Fertility and Sterility, vol. 91, no. 4, pp. 1204–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Emre, M. Akin, I. Isikgonul, O. Yuksel, A. Z. Anadol, and C. Cifter, “Comparison of intraperitoneal honey and sodium hyaluronate-carboxymethylcellulose (Seprafilm) for the prevention of postoperative intra-abdominal adhesions,” Clinics, vol. 64, no. 4, pp. 363–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Aysan, H. Bektas, and A. Kaygusuz, “Efficacy of glycerol in preventing postoperative peritoneal adhesions,” Journal of Obstetrics and Gynaecology Research, vol. 36, no. 3, pp. 639–645, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Aysan, H. Bektas, and F. Ersoz, “A new approach to postoperative peritoneal adhesions: prevention of peritoneal trauma by aloe vera gel,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 149, no. 2, pp. 195–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Aysan, H. Bektas, and A. Kaygusuz, “Efficacy of octyl methoxycinnamate in preventing postoperative peritoneal adhesions: an experimental model,” Journal of Obstetrics and Gynaecology Research, vol. 35, no. 6, pp. 1102–1108, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Lalountas, K. D. Ballas, C. Skouras et al., “Preventing intraperitoneal adhesions with atorvastatin and sodium hyaluronate/carboxymethylcellulose: a comparative study in rats,” American Journal of Surgery, vol. 200, no. 1, pp. 118–123, 2010. View at Google Scholar
  8. E. Ersoy, V. Ozturk, A. Yazgan, M. Ozdogan, and H. Gundogdu, “Comparison of the two types of bioresorbable barriers to prevent intra-abdominal adhesions in rats,” Journal of Gastrointestinal Surgery, vol. 13, no. 2, pp. 282–286, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Aritaş, A. Akcan, A. R. Erdoǧan, H. Akgün, R. Saraymen, and H. Akyildiz, “Effects of melatonin and phospholipid on adhesion formation and correlation with vascular endothelial growth factor expression in rats,” Ulusal Travma ve Acil Cerrahi Dergisi, vol. 15, no. 5, pp. 416–422, 2009. View at Google Scholar · View at Scopus
  10. A. N. Imudia, S. Kumar, G. M. Saed, and M. P. Diamond, “Pathogenesis of intra-abdominal and pelvic adhesion development,” Seminars in Reproductive Medicine, vol. 26, no. 4, pp. 289–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. Cahill and H. P. Redmond, “Cytokine orchestration in post-operative peritoneal adhesion formation,” World Journal of Gastroenterology, vol. 14, no. 31, pp. 4861–4866, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. D. M. Evans, K. McAree, D. P. Guyton, N. Hawkins, and K. Stakleff, “Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions,” American Journal of Surgery, vol. 165, no. 2, pp. 229–232, 1993. View at Google Scholar · View at Scopus
  13. M. C. Parker, H. Ellis, B. J. Moran et al., “Postoperative adhesions: ten-year follow-up of 12,584 patients undergoing lower abdominal surgery,” Diseases of the Colon and Rectum, vol. 44, no. 6, pp. 822–829, 2001. View at Google Scholar · View at Scopus
  14. D. Robertson, G. Lefebvre, N. Leyland et al., “Society of Obstetricians and Gynaecologists of Canada: adhesion prevention in gynaecological surgery,” Journal of Obstetrics and Gynaecology Canada, vol. 32, no. 6, pp. 598–608, 2010. View at Google Scholar
  15. A. Imai and N. Suzuki, “Topical non-barrier agents for postoperative adhesion prevention in animal models,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 149, no. 2, pp. 131–135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Ellis, “Intraabdominal and postoperative peritoneal adhesions,” Journal of the American College of Surgeons, vol. 200, no. 5, pp. 643–644, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Akyildiz, A. Akcan, E. Sozuer, C. Kucuk, N. Yilmaz, and K. Deniz, “The preventive effect of Met-RANTES on postoperative intraperitoneal adhesion formation in the rat model,” Surgery, vol. 144, no. 3, pp. 404–409, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Ferrara, K. J. Hillan, and W. Novotny, “Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy,” Biochemical and Biophysical Research Communications, vol. 333, no. 2, pp. 328–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Toi, T. Matsumoto, and H. Bando, “Vascular endothelial growth factor:its prognostic, predictive, and therapeutic implications,” Lancet Oncology, vol. 2, no. 11, pp. 667–673, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. A. D. Thornton, P. Ravn, M. Winslet, and K. Chester, “Angiogenesis inhibition with bevacizumab and the surgical management of colorectal cancer,” British Journal of Surgery, vol. 93, no. 12, pp. 1456–1463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. M. P. Diamond, E. El-Hammady, A. Munkarah, E. J. Bieber, and G. Saed, “Modulation of the expression of vascular endothelial growth factor in human fibroblasts,” Fertility and Sterility, vol. 83, no. 2, pp. 405–409, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. T. R. Howdieshell, D. Callaway, W. L. Webb et al., “Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation,” Journal of Surgical Research, vol. 96, no. 2, pp. 173–182, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. R. A. Cahill, J. H. Wang, S. Soohkai, and H. P. Redmond, “Mast cells facilitate local VEGF release as an early event in the pathogenesis of postoperative peritoneal adhesions,” Surgery, vol. 140, no. 1, pp. 108–112, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Yanagisawa, K. Fujimoto-Ouchi, K. Yorozu, Y. Yamashita, and K. Mori, “Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models,” Oncology Reports, vol. 22, no. 2, pp. 241–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. E. T. Pavlidis, K. D. Ballas, N. G. Symeonidis et al., “The effect of bevacizumab on colon anastomotic healing in rats,” International Journal of Colorectal Disease, vol. 25, no. 12, pp. 1465–1473, 2010. View at Google Scholar
  26. W. J. Kim, H. O. Jeong, and S. K. Chung, “The effect of bevacizumab on corneal neovascularization in rabbits,” Korean Journal of Ophthalmology, vol. 24, no. 4, pp. 230–236, 2010. View at Google Scholar
  27. V. Hsei, G. G. DeGuzman, A. Nixon, and J. Gaudreault, “Complexation of VEGF with bevacizumab decreases VEGF clearance in rats,” Pharmaceutical Research, vol. 19, no. 11, pp. 1753–1756, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Ferrara, K. J. Hillan, H. P. Gerber, and W. Novotny, “Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer,” Nature Reviews Drug Discovery, vol. 3, no. 5, pp. 391–400, 2004. View at Google Scholar · View at Scopus
  29. Y. Wang, D. Fei, M. Vanderlaan, and A. Song, “Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro,” Angiogenesis, vol. 7, no. 4, pp. 335–345, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Moraloglu, H. Işik, S. Kiliç et al., “Effect of bevacizumab on postoperative adhesion formation in a rat uterine horn adhesion model and the correlation with vascular endothelial growth factor and Ki-67 immunopositivity,” Fertility and Sterility. In press.